Delirious Mania Case Reported Persistent Illness Despite High-Dose Lorazepam Before Lithium Response

Written by

in

A case described prolonged delirious mania during several treatment attempts. Later improvement with lithium did not establish a controlled comparison with lorazepam.

The clinical sequence

The patient had overlapping manic, delirious, and catatonic features. High-dose lorazepam, several antipsychotics, and valproate produced little improvement over twenty-six days.

The authors reported a dramatic response after lithium was introduced and discussed possible mechanisms. They also noted the diagnostic overlap with other serious neuropsychiatric syndromes.

One course cannot define a treatment hierarchy

The illness evolved while several medicines were changed. Delayed effects, natural fluctuation, co-treatment, and the underlying diagnosis complicate attribution.

The paper cannot establish a general lorazepam failure rate or prove that lithium should replace benzodiazepines for every catatonic presentation. Its value is a carefully described treatment-resistant case. Forensic interpretation should preserve the symptoms, examination, laboratory findings, medication sequence, and time to response rather than applying a broad label such as treatment failure without specifying what was actually tried.

Source paper

Original analysis of the supplied journal article, identified as PMC8269925.

Related research

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *